Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/180262
Registo completo
Campo DCValorIdioma
dc.contributor.authorMaurício, Elisabete Muchagato-
dc.contributor.authorBranco, Patrícia-
dc.contributor.authorAraújo, Ana Luiza Barros-
dc.contributor.authorRoma-Rodrigues, Catarina-
dc.contributor.authorLima, Katelene-
dc.contributor.authorDuarte, Maria Paula-
dc.contributor.authorFernandes, Alexandra R.-
dc.contributor.authorAlbergaria, Helena-
dc.date.accessioned2025-03-07T22:40:32Z-
dc.date.available2025-03-07T22:40:32Z-
dc.date.issued2024-09-
dc.identifier.issn2079-6382-
dc.identifier.otherPURE: 107349036-
dc.identifier.otherPURE UUID: 919382f0-cc6c-40fe-9f89-212b82a94770-
dc.identifier.otherScopus: 85205240387-
dc.identifier.otherWOS: 001326109700001-
dc.identifier.otherPubMed: 39335054-
dc.identifier.otherORCID: /0000-0003-2054-4438/work/179617818-
dc.identifier.urihttp://hdl.handle.net/10362/180262-
dc.description© 2024 by the authors. Licensee MDPI, Basel, Switzerland.-
dc.description.abstractBiotechnological active peptides are gaining interest in the cosmetics industry due to their antimicrobial, anti-inflammatory, antioxidant, and anti-collagenase (ACE) effects, as well as wound healing properties, making them suitable for cosmetic formulations. The antimicrobial activity of peptides (2–10 kDa) secreted by Saccharomyces cerevisiae Ethanol-Red was evaluated against dermal pathogens using broth microdilution and challenge tests. ACE was assessed using a collagenase activity colorimetric assay, antioxidant activity via spectrophotometric monitoring of nitrotetrazolium blue chloride (NBT) reduction, and anti-inflammatory effects by quantifying TNF-α mRNA in lipopolysaccharides (LPS)-exposed dermal fibroblasts. Wound healing assays involved human fibroblasts, endothelial cells, and dermal keratinocytes. The peptides (2–10 kDa) exhibited antimicrobial activity against 10 dermal pathogens, with the Minimum Inhibitory Concentrations (MICs) ranging from 125 µg/mL for Staphylococcus aureus to 1000 µg/mL for Candida albicans and Streptococcus pyogenes. In the challenge test, peptides at their MICs reduced microbial counts significantly, fulfilling ISO 11930:2019 standards, except against Aspergillus brasiliensis. The peptides combined with MicrocareⓇ SB showed synergy, particularly against C. albicans and A. brasilensis. In vitro, the peptides inhibited collagenase activity by 41.8% and 94.5% at 250 and 1000 µg/mL, respectively, and demonstrated antioxidant capacity. Pre-incubation with peptides decreased TNF-α expression in fibroblasts, indicating anti-inflammatory effects. The peptides do not show to promote or inhibit the angiogenesis of endothelial cells, but are able to attenuate fibrosis, scar formation, and chronic inflammation during the final phases of the wound healing process. The peptides showed antimicrobial, antioxidant, ACE, and anti-inflammatory properties, highlighting their potential as multifunctional bioactive ingredients in skincare, warranting further optimization and exploration in cosmetic applications.en
dc.language.isoeng-
dc.relationinfo:eu-repo/grantAgreement/FCT/OE/SFRH%2FBPD%2F124612%2F2016/PT-
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBII-BIO%2F31761%2F2017/PT-
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04378%2F2020/PT-
dc.relationinfo:eu-repo/grantAgreement/FCT/Concurso para Atribuição do Estatuto e Financiamento de Laboratórios Associados (LA)/LA%2FP%2F0140%2F2020/PT-
dc.rightsopenAccess-
dc.subjectanti-ageing-
dc.subjectanti-collagenase-
dc.subjectanti-inflammatory-
dc.subjectantimicrobial peptides-
dc.subjectbiopreservatives-
dc.subjectbiotechnological active peptides-
dc.subjectSaccharomyces cerevisiae-
dc.subjectMicrobiology-
dc.subjectBiochemistry-
dc.subjectPharmacology, Toxicology and Pharmaceutics(all)-
dc.subjectMicrobiology (medical)-
dc.subjectInfectious Diseases-
dc.subjectPharmacology (medical)-
dc.subjectSDG 3 - Good Health and Well-being-
dc.subjectSDG 7 - Affordable and Clean Energy-
dc.subjectSDG 9 - Industry, Innovation, and Infrastructure-
dc.subjectSDG 12 - Responsible Consumption and Production-
dc.titleEvaluation of Biotechnological Active Peptides Secreted by Saccharomyces cerevisiae with Potential Skin Benefits-
dc.typearticle-
degois.publication.issue9-
degois.publication.titleAntibiotics-
degois.publication.volume13-
dc.peerreviewedyes-
dc.identifier.doihttps://doi.org/10.3390/antibiotics13090881-
dc.description.versionpublishersversion-
dc.description.versionpublished-
dc.contributor.institutionUCIBIO - Applied Molecular Biosciences Unit-
dc.contributor.institutionDCV - Departamento de Ciências da Vida-
dc.contributor.institutionFaculdade de Ciências e Tecnologia (FCT)-
dc.contributor.institutionDQ - Departamento de Química-
dc.contributor.institutionMEtRICS - Centro de Engenharia Mecânica e Sustentabilidade de Recursos-
Aparece nas colecções:Home collection (FCT)

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
antibiotics-13-00881.pdf2,97 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.